The relationship between work-related outcomes and symptoms in early breast cancer survivors receiving adjuvant endocrine therapy.
Breast cancer survivors
Endocrine therapy
Symptoms
Work
Journal
Asia-Pacific journal of oncology nursing
ISSN: 2347-5625
Titre abrégé: Asia Pac J Oncol Nurs
Pays: United States
ID NLM: 101673157
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
06
11
2021
accepted:
09
01
2022
entrez:
2
5
2022
pubmed:
3
5
2022
medline:
3
5
2022
Statut:
epublish
Résumé
This study examined the relationship between symptom burdens and work-related outcomes, including work participation and overall work impairment (OWI) among breast cancer survivors (BCS) receiving adjuvant endocrine therapy (AET). This was a cross-sectional study with 140 BCS of working age receiving AET. Data were collected using self-report questionnaires that included an assessment of symptoms and their employment status, and OWI. Data were analyzed using descriptive statistics and multiple logistic regression analysis. A total of 111 (79%) survivors reported being employed at the time of the survey. Symptom burdens were not associated with unemployment. Of the 110 working BCS receiving AET, symptom burdens were significantly related to a higher degree of OWI (OR = 2.14, 95% CI, 1.58-2.89, Participating BCS receiving AET continued to work while experiencing symptoms, with survivors who experienced high symptom burdens being negatively affected in their work life. Healthcare providers need to assess and manage symptoms and their impact on work, with the help of employers, to improve the quality of work life of BCS receiving AET.
Identifiants
pubmed: 35494090
doi: 10.1016/j.apjon.2022.01.003
pii: S2347-5625(22)00003-8
pmc: PMC9052840
doi:
Types de publication
Journal Article
Langues
eng
Pagination
174-178Informations de copyright
© 2022 The Authors.
Références
Breast Cancer Res Treat. 2020 Feb;180(1):63-71
pubmed: 31938939
Support Care Cancer. 2018 Aug;26(8):2815-2824
pubmed: 29511953
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13051
pubmed: 31033073
Support Care Cancer. 2014 Apr;22(4):937-45
pubmed: 24271937
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
BMC Cancer. 2021 Jan 21;21(1):86
pubmed: 33478405
Cancer. 2018 May 1;124(9):2026-2035
pubmed: 29437204
Cancer Nurs. 2019 Sep/Oct;42(5):E19-E30
pubmed: 30138143
Ann Oncol. 2019 Nov 1;30(11):1784-1795
pubmed: 31591636
Psychooncology. 2014 May;23(5):481-92
pubmed: 24375630
J Cancer Surviv. 2008 Dec;2(4):296-302
pubmed: 19003541
J Pain Symptom Manage. 1997 Feb;13(2):63-74
pubmed: 9095563
J Cancer Surviv. 2014 Dec;8(4):657-70
pubmed: 24993807
J Clin Oncol. 2014 Jul 20;32(21):2255-69
pubmed: 24868023
Gynecol Oncol. 2012 Mar;124(3):437-43
pubmed: 22138013
J Patient Rep Outcomes. 2017;2(1):2
pubmed: 29757309
BMC Cancer. 2018 Jul 11;18(1):732
pubmed: 29996816
J Nippon Med Sch. 2004 Oct;71(5):314-22
pubmed: 15514448
Psychooncology. 2013 Jun;22(6):1208-19
pubmed: 22888070
J Adv Nurs. 2021 May;77(5):2144-2154
pubmed: 33368563
JAMA Oncol. 2015 Nov;1(8):1051-9
pubmed: 26270597
J Cancer Surviv. 2018 Apr;12(2):246-255
pubmed: 29222703
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
J Clin Oncol. 2016 Mar 10;34(8):816-24
pubmed: 26786934
Eur J Cancer Care (Engl). 2018 Nov;27(6):e12919
pubmed: 30253019
Oncol Nurs Forum. 2014 Nov 1;41(6):660-8
pubmed: 25355021
Work. 2018;61(3):463-476
pubmed: 30400123
Support Care Cancer. 2017 Mar;25(3):709-718
pubmed: 27873016